Search Results - "Pacchiana, C M"

Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition : Insights from the platelet glycoprotein IIb/IIIa in unstable angina : Receptor suppression using integrilin therapy (PURSUIT) trial by LINCOFF, A. M, HARRINGTON, R. A, BERDAN, L. G, KITT, M. M, SIMOONS, M. L, TOPOL, E. J, CALIFF, R. M, HOCHMAN, J. S, GUERCI, A. D, OHMAN, E. M, PEPINE, C. J, KOPECKY, S. L, KLEIMAN, N. S, PACCHIANA, C. M

“…A multinational, randomized, placebo-controlled trial (Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy,…”
Get full text

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial by Tcheng, J E, O'Shea, J C, Cohen, E A, Pacchiana, C M

“…The platelet glycoprotein IIb/IIIa inhibitors, although effective in reducing ischaemic complications of percutaneous coronary intervention, are used in few…”
Get full text

Design and methodology of the ESPRIT trial: Evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention by O’Shea, J.Conor, Madan, Mina, Cantor, Warren J., Pacchiana, Cynthia M., Greenberg, Sally, Joseph, Diane M., Kitt, Michael M., Lorenz, Todd J., Tcheng, James E.

“…Background Clinical trials of the glycoprotein (GP) IIb/IIIa inhibitors have shown that these potent antiplatelet agents are effective in reducing the ischemic…”
Get full text

Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: Results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial by Cohen, Mauricio G., Pacchiana, Cynthia M., Corbalán, Ramón, Isea Perez, Jesús E., Ponte, Carlos I., Oropeza, Elsa Silva, Diaz, Rafael, Paolasso, Ernesto, Izasa, Daniel, Rodas, Marco A., Urrutia, Carlos E., Harrington, Robert A., Topol, Eric J., Califf, Robert M.

“…Background Although more than 9500 patients have been enrolled in major clinical trials in Latin America, practice patterns in this region have rarely been…”
Get full text

In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial) by Cohen, David J., O’Shea, J.Conor, Pacchiana, Cindy M., Levine, Glenn, Sarembock, Ian, Slater, James, Conn, Eric, Smith, Jack, Tcheng, James E.

“…Among patients who underwent coronary stenting and were randomized to eptifibatide (n=1,040) or placebo (n=1,024), use of eptifibatide reduced initial…”
Get full text